You are here: Industry Insights > COVID-19

News List

US expands COVID-19 convalescent plasma treatment trials europeanpharmaceuticalreview
September 27, 2020
Operation Warp Speed and the NIH are funding the expansion of two trials evaluating the efficacy of convalescent plasma therapy in hospitalised COVID-19 patients.
GRAM, J&J Enter COVID-19 Vax Manufacturing Pact contractpharma
September 27, 2020
GRAM to provide advanced aseptic fill and finish services for supply of J&J’s SARS-CoV-2 vaccine candidate from its facility in Grand Rapids, MI.
Novavax, Par Sterile Products Enter COVID-19 Vax Mfg. Pact contractpharma
September 27, 2020
Par Sterile's Rochester facility began production of NVX-CoV2373 final drug product, with initial batches to be used in Novavax' Phase III trial.
Government asks States/UTs to establish robust storage mechanism for COVID-19 vaccines expresspharma
September 27, 2020
It has also requested State/UT authorities to identify the sites for urgent installation of bulk storage cold chain equipment.
Bacterial viperins prove effective against human viruses: Researchers expresspharma
September 27, 2020
The molecules produced by the bacterial viperins are currently undergoing testing against human viruses such as the influenza virus and COVID-19.
Panacea Biotec completes Phase I/II study of DengiAll, a tetravalent dengue vaccine candidate expresspharma
September 27, 2020
The company has approached DGCI to seek accelerated review of its data to bring DengiAIl to market quickly.
RDIF and ChemRar agree to supply Avifavir to 17 countries pharmaceutical-technology
September 27, 2020
The Russian Direct Investment Fund (RDIF) and ChemRar Group will be supplying a Covid-19 drug, Avifavir, to 17 countries.
ARCA Submits IND Application for AB201 as Potential COVID-19 Treatment americanpharmaceuticalreview
September 27, 2020
ARCA biopharma has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) under the Coronavirus Treatment Acceleration Program (CTAP) to evaluate AB201 for the treatment of patients hospitalized with ...
Beech Tree Labs Selects Curavit Clinical Research for Fully Virtual COVID-19 Clinical Trial americanpharmaceuticalreview
September 27, 2020
Beechtree Labs has chosen Curavit Clinical Research for a fully decentralized clinical trial to investigate a Covid-19 therapy. The FDA-authorized phase 2 clinical study will evaluate the effect of Beech Tree's BTL-TML therapy on mean duration and ...
FDA Grants IND, Approves Trial Protocol of Inhaled Ampion for COVID-19 americanpharmaceuticalreview
September 27, 2020
Ampio Pharmaceuticals announces the receipt of an Investigational New Drug (IND) from the U.S. Food and Drug Administration (FDA), allowing the Company to proceed with clinical trials for the use of Ampion as an inhalation therapy for respiratory ...